Earnings

CG Oncology Q3 EPS $(0.64) Beats $(0.82) Estimate, Sales $1.604M Beat $643.584K Estimate

Nov 6, 2026 · 08:46 AM ET· updated 1h ago

CG Oncology (NASDAQ:CGON) reported quarterly losses of $(0.64) per share which beat the analyst consensus estimate of $(0.82) by 21.95 percent. This is a 12.28 percent decrease over losses of $(0.57) per share from the

Why It Matters

CG Oncology lost less money than Wall Street expected this quarter. When a company loses less than predicted, it shows better control of costs.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

CGON72.57

+7.77 (+11.98%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.